You are here

Prices & Quotes - UK Markets - 4basebio (4BB)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Up 650.00p
Change Today:
10.00p
Market Cap:
80.06m
Sector:
Pharmaceuticals & Biotechnology

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

Today (Thu 20 Jan 22)

1 Day Chart

Last 6 Month

6 Month Chart

4basebio Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.20 (0.53) (5.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.46 (0.72) (8.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

4basebio Market Data

Currency UK Pounds
Price 650.00p
Change Today 10.00p
52 Week High 765.00p
52 Week Low 310.00p
Volume 1,100
Shares Issued 12.32m
Market Cap 80.06m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
Not Available
Price Trend
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Income
Not Available
Growth
Not Available
Price Chg 6m
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
P/E
Not Available
PEG
Not Available
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
Not Available

4basebio Dividends

No dividends found

Trades for 20-Jan-2022

Time Volume / Share Price
14:00 100 @ 620.00p
08:01 1,000 @ 650.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth